Triple-negative breast cancer does not respond to targeted breast cancer treatments, which limits treatment to primarily chemotherapy for now.

Triple-positive breast cancer involves tumors positive for estrogen, progesterone, and HER2 receptors, affecting treatment decisions and strategies. Diagnosis includes imaging and biopsy to confirm ...

Rb1 loss may serve as a predictive biomarker to guide new targeted therapies for select breast cancers resistant to standard ...

New research shows that women living near Superfund sites are more likely to develop aggressive and metastatic breast cancers ...

Triple Negative Breast Cancer (TNBC) is one of the most aggresive types of breast cancer. It’s the kind of breast cancer that doesn’t have estrogen receptors, progesterone receptors, and human ...

Triple negative breast cancer (TNBC) represents approximately 10-15% of all breast cancer diagnoses but accounts for a disproportionately high percentage of breast cancer deaths. What sets this ...

Datopotamab deruxtecan received FDA approval for HR+/HER2– breast cancer, improving progression-free survival and overall ...

A large study showed that for most patients, having both breasts removed after cancer was detected in one made no difference. By Gina Kolata For the more than 310,000 women diagnosed with breast ...

Groundbreaking research suggests that Triple-Negative Breast Cancer is "addicted" to lipids, prompting experts to warn ...

Linda Perry is revealing her double mastectomy after a "stressful," secret battle with triple-negative breast cancer. The rock legend, who originally believed her symptoms were due to stress from ...